In addition, another study showed that phosphatase and tensin homolog (PTEN) loss, which acts as a negative regulator of the AKT/mTOR signaling pathway, increases the expression of AKT, CDK4 and CDK2 in CDK4/6i-resistant BC cell models [155]. The gene discussed is CDK2; the disease is breast cancer.